Stocks to follow on Wall Street (updated)


(Updated with Exxon Mobil, Chevron, Centene, Aon, AbbVie, T Rowe, Colgate, Sketchers, Pfizer, Western Digital, Tesla)

PARIS, April 26 (Reuters) – Main values ​​to follow on Friday on Wall Street where futures contracts on the main indices suggest an opening up 0.14% for the Dow Jones, 0.69% for Standard & Poor’s 500 and 0.94% for the Nasdaq:

* ALPHABET, Google’s parent company, announced Thursday the first dividend in its history and a $70 billion share buyback program, while reassuring its advertising revenue. The title takes 12% before the opening.

* MICROSOFT published quarterly results on Thursday that exceeded Wall Street expectations thanks to the success of its new features linked to artificial intelligence (AI) in its cloud computing services and its business software. The title gained 4.3% before the opening.

Read also

* TESLA, NVIDIA, META PLATFORMS AMAZON.COM take between 1% and 3.1% before the opening, in the wake of Alphabet and Microsoft.

* INTEL said on Thursday it expected revenue and profit below expectations in the second quarter due to weak demand for its chips intended for traditional data centers and personal computers. The stock lost 7.9% before the opening.

* SNAP – The group’s quarterly revenue and user growth were higher than Wall Street’s expectations on Thursday, thanks to improvements to Snap’s advertising system. The title takes 24% before the opening.

* EXXON MOBIL missed analysts’ estimates on Friday, with profit sliding 28% year-on-year in the first quarter, with falling refining margins and natural gas prices having a heavy impact.

* CHEVRON beat estimates for its first quarter profit on Friday, as increased production volumes helped offset weak natural gas prices.

* CENTENE – First-quarter profit was higher than Wall Street estimates, thanks to higher premiums from its commercial insurance business.

* AON reported on Friday an increase in its profit in the first quarter, thanks to the increase in interest received on investments as well as on funds held in trust.

* ABBVIE raised its annual profit forecast on Friday, after strong sales of its immunology drug Skyrizi and its cancer drug Imbruvica helped the company beat Wall Street estimates for its first quarter.

* T ROWE PRICE – First quarter profit exceeded expectations thanks to the market effect which supported outstandings and mitigated the impact of cash outflows, the group said on Friday.

* COLGATE-PALMOLIVE raised its annual organic revenue growth forecasts on Friday, banking on the resilience of demand for its personal care and pet nutrition products.

* TESLA – American automobile safety regulators announced Friday that they had opened an investigation into Tesla’s recall of more than 2 million vehicles.

* PFIZER – The US Food and Drug Administration on Friday approved the group’s gene therapy for a type of hemophilia.

* SKECHERS USA – The group forecasts annual earnings per share of between $3.95 and $4.10, compared to $4.01 estimated by analysts.

* WESTERN DIGITAL – Benchmark raises its recommendation to “buy”.

* T-MOBILE US on Thursday raised its forecast for annual growth in the number of subscribers to its plans, with more customers taking advantage of its discounted offers and the expansion of the 5G network.

* GILEAD SCIENCES reported a first-quarter loss on Thursday, linked to a $3.9 billion charge for its recent acquisition of liver drug developer CymaBay Therapeutics, as revenue rose 5% over one year.

* CHEMOURS said Thursday that its chief financial officer, Jonathan Lock, resigned on April 23.

* CAPITAL ONE FINANCIAL – First-quarter profit rose 35% as customers paid more on the company’s credit cards amid rising interest rates.

* CIGNA plans to make biosimilars of Humira, ABBVIE’s flagship arthritis drug, available free of charge to eligible patients, the health insurer said Thursday.

* FAIR ISAAC posted a rise in second-quarter profit on Thursday, helped by strong demand for its credit scoring solutions and software.

* KLA announced on Thursday that it forecast fourth-quarter revenue above analyst expectations, anticipating strong demand for its chip manufacturing tools supported by demand for AI applications.

* JUNIPER NETWORKS missed Wall Street estimates for its first-quarter revenue on Thursday, with demand being sluggish in an uncertain economic context.

* ARTHUR J. GALLAGHER – The insurance broker posted a jump in first-quarter profit on Thursday, thanks to higher commissions and fees. The stock gained 2.7% after the close.

* WESTERN DIGITAL – Quarterly revenues and profit were above expectations on Thursday, thanks to stronger demand for data storage.

* HARTFORD FINANCIAL SERVICES reported on Thursday an increase in its profit in the first quarter, the insurer having benefited from an increase in investment income.

* ATLASSIAN – The software maker on Thursday forecast fourth-quarter revenue above Wall Street estimates, citing an increase in demand for its cloud computing services.

* VERISIGN – The Internet services company announced on Thursday a 5.5% increase in its turnover in the first quarter, helped by constant demand for domain name registrations.

* EDWARDS LIFESCIENCES published a higher quarterly profit on Thursday due to strong demand for its artificial heart valves and other medical devices.

* PRINCIPAL FINANCIAL reported on Thursday an increase in its profit in the first quarter, thanks to the increase in premiums and investment income.

* DOW – JP Morgan raises its recommendation from “neutral” to “outperform”. (Written by Corentin Chappron, edited by Kate Entringer)

©2024 Thomson Reuters, all rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. “Reuters” and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.



Source link -87